ELIZABETH KUNSELMAN: Open Payments
NPI 1821194051 · CAPITOLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 16 payments from 4 companies in 2025. Trend: 2023 $772 · 2024 $133 · 2025 $837
Food & beverage: $777Long term medical supply or device loan: $60
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $533 |
| Dexcom, Inc. | 2 | $139 |
| SANOFI-AVENTIS U.S. LLC | 1 | $118 |
| Novo Nordisk Inc | 1 | $48 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, TZIELD, FREESTYLE INSULINX.
Industry payments across CA — which companies pay providers there.
